Page last updated: 2024-09-02

dihydroergocryptine and levodopa

dihydroergocryptine has been researched along with levodopa in 4 studies

Compound Research Comparison

Studies
(dihydroergocryptine)
Trials
(dihydroergocryptine)
Recent Studies (post-2010)
(dihydroergocryptine)
Studies
(levodopa)
Trials
(levodopa)
Recent Studies (post-2010) (levodopa)
218217,7741,9004,946

Protein Interaction Comparison

ProteinTaxonomydihydroergocryptine (IC50)levodopa (IC50)
integrase, partialHuman immunodeficiency virus 10.5939
lens epithelium-derived growth factor p75Homo sapiens (human)0.5939
Epidermal growth factor receptorHomo sapiens (human)2.88
Tyrosine-protein kinase LckHomo sapiens (human)3.729
Tyrosine-protein kinase FynHomo sapiens (human)2.146
Polyunsaturated fatty acid lipoxygenase ALOX15Oryctolagus cuniculus (rabbit)2.258

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gasser, T; Pöpperl, G; Ruzicka, E; Schwarz, J; Storch, A; Tatsch, K1
Magnani, P; Mailland, E; Ottillinger, B1
Goetz, CG; Poewe, W; Rascol, O; Sampaio, C1
Gille, G; Radad, K; Rausch, WD; Reichmann, H1

Reviews

1 review(s) available for dihydroergocryptine and levodopa

ArticleYear
Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004.
    Movement disorders : official journal of the Movement Disorder Society, 2005, Volume: 20, Issue:5

    Topics: Amantadine; Antiparkinson Agents; Apomorphine; Benzophenones; Benzothiazoles; Bromocriptine; Cabergoline; Catechol O-Methyltransferase Inhibitors; Deep Brain Stimulation; Dihydroergocryptine; Ergolines; Fetal Tissue Transplantation; Globus Pallidus; Humans; Indans; Indoles; Levodopa; Lisuride; Mesencephalon; Monoamine Oxidase Inhibitors; Neurosurgical Procedures; Nitrophenols; Parkinson Disease; Pergolide; Piribedil; Pramipexole; Selegiline; Thiazoles; Tolcapone

2005

Trials

2 trial(s) available for dihydroergocryptine and levodopa

ArticleYear
Comparison of alpha-dihydroergocryptine and levodopa monotherapy in Parkinson's disease: assessment of changes in DAT binding with [123I]IPT SPECT.
    Journal of neural transmission (Vienna, Austria : 1996), 2004, Volume: 111, Issue:8

    Topics: Adolescent; Aged; Caudate Nucleus; Dihydroergocryptine; Dopamine Plasma Membrane Transport Proteins; Double-Blind Method; Female; Follow-Up Studies; Humans; Levodopa; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Neostriatum; Nerve Tissue Proteins; Parkinson Disease; Putamen; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Tropanes

2004
Alpha-dihydroergocryptine in the long-term therapy of Parkinson's disease.
    Arzneimittel-Forschung, 2004, Volume: 54, Issue:10

    Topics: Aged; Antiparkinson Agents; Dihydroergocryptine; Female; Gait Disorders, Neurologic; Humans; Levodopa; Male; Muscle Rigidity; Parkinson Disease; Posture; Psychomotor Performance; Speech Disorders; Tremor

2004

Other Studies

1 other study(ies) available for dihydroergocryptine and levodopa

ArticleYear
Synergistic effect of alpha-dihydroergocryptine and L-dopa or dopamine on dopaminergic neurons in primary culture.
    Journal of neural transmission (Vienna, Austria : 1996), 2006, Volume: 113, Issue:9

    Topics: 1-Methyl-4-phenylpyridinium; Animals; Carbidopa; Cell Count; Cells, Cultured; Dihydroergocryptine; Dopamine; Dopamine Agents; Dopamine Antagonists; Drug Synergism; Female; Lactic Acid; Levodopa; Mice; Neuroglia; Neurons; Pregnancy; Sulpiride; Tyrosine 3-Monooxygenase

2006